Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Nino Lomidze

Nino Lomidze

Ilia State University Georgia

Raffaele Pilla

Raffaele Pilla

St. John of God Hospital Italy

Felix-Martin Werner

Felix-Martin Werner

Euro Akademie Pößneck Germany

Fresthel Monica M. Climacosa

Fresthel Monica M. Climacosa

University of the Philippines Philippines

Jesus Lagunas Garza

Jesus Lagunas Garza

Hospital Infantil de México Federico Gómez Mexico

Boulenouar Mesraoua

Boulenouar Mesraoua

Weill Cornell Medical College Qatar

Zhenhuan LIU

Zhenhuan LIU

Guangzhou University of Chinese Medicine China

MAS Ahmed

MAS Ahmed

Queen’s Hospital UK


About Conference

Conference Series invites all participants worldwide to attend the 14th Global Alzheimer’s Summit on August 13-14, 2024 in Amsterdam, Netherlands cordially invites you to Oral presentations, poster presentations and exhibitors sharing their knowledge. The main theme of the conference is " Alzheimers: Tackling depression, anxiety, and emotional well-being challenges effectively". The conference aims to extend its reach in the field of Neuroscience and lectures by experts and presentations by young researchers will keep the conference inspired and keep you enthusiastic. We feel that our expert organizing committee is our major asset. But your presence at the venue adds another feather to the crown of Alzheimers-2024.

Alzheimer’s, is a progressive disease beginning with mild memory loss and possibly leading to loss of the ability to carry on a conversation and respond to the environment. Alzheimers-2024 consists of the following 15 tracks and sessions designed to provide a comprehensive session that addresses current issues in Neuroscience. Global Alzheimer’s Summit can answer business problems that traditionally take too long to solve. 14th Global Alzheimer’s Summit emphasizes on how importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Sessions & Tracks

Track 1: Alzheimer’s Diseases

Alzheimer's disease ranks as the most common type of dementia. It manifests as a progressive ailment that initiates with minor memory deficits and may ultimately progress to the point where individuals lose their capacity to engage in conversations and respond to their surroundings. This condition predominantly affects regions of the brain responsible for cognition, memory, and language. The precise etiology of Alzheimer's disease remains incompletely elucidated, but it likely arises from a complex interplay of factors, including age-related alterations in the brain such as atrophy, inflammation, vascular damage, and disruptions in cellular energy metabolism, which can lead to neuronal damage and impact other brain cells.

Track 2: Anxiety & Depression

Anxiety encompasses feelings of fear, apprehension, and discomfort, often accompanied by symptoms like perspiration, restlessness, tension, and a heightened heart rate. It can be a typical response to stress. Depression, on the other hand, constitutes a mood disorder characterized by persistent sadness and a diminished interest in life. Referred to as major depressive disorder or clinical depression, it exerts a profound influence on your emotions, thoughts, behaviours, and can give rise to a range of emotional and physical challenges.

Experiencing traumatic or stress-inducing events, such as physical or sexual abuse, the loss of a loved one, or financial difficulties, encountering significant life changes, even if they were planned, grappling with medical conditions like cancer, stroke, or chronic pain, or taking certain medications can contribute to the onset of depression.

Track 3: Child and Adolescent Psychiatry

Child and adolescent psychiatrists are dedicated to fostering emotional well-being and addressing mental health concerns, encompassing the prevention, early intervention, and treatment of various forms of mental illness, emotional disruptions, and atypical behaviour. They serve a broad spectrum of patients, ranging from those with mild, episodic disorders to individuals grappling with chronic and long-lasting conditions.

Child and adolescent psychiatry operates at the intersection of psychiatry, paediatric medicine, and neurology. A clinician in this field is tasked with gathering a comprehensive medical history, conducting relevant physical examinations, and, when necessary, performing laboratory assessments. These measures serve to either support or refute the preliminary diagnosis, taking into account the holistic biopsychosocial perspective.

Track 4: Clinical Neurology, Neurophysiology and Neurosurgeries

Clinical Neurology and Neurosurgery is committed to the dissemination of research papers and reports focusing on the clinical dimensions of neurology and neurosurgery. Neurophysiology, within the realm of health sciences, is a field concerned with the measurement and evaluation of the functional aspects of the nervous system, as opposed to its anatomical structure. Clinical neuroscience delves into strategies for managing and averting neurological disorders and addresses the rehabilitation of individuals whose nervous systems have sustained injuries.

Track 5: Dementia

Dementia refers to the deterioration of cognitive abilities, including thinking, memory, and reasoning, to an extent that disrupts a person's daily life and activities. Some individuals with dementia may experience difficulty in managing their emotions and may undergo alterations in their personalities. This condition arises from the impairment or loss of nerve cells and their interconnections in the brain, with the specific symptoms contingent upon the affected brain regions. Dementia exhibits considerable variability in its impact on individuals.

Track 6: Mental health

Mental health encompasses our emotional, psychological, and social well-being, playing a pivotal role in shaping our cognition, emotions, and behavior. It significantly influences our capacity to cope with stress, cultivate relationships, and make sound decisions. The importance of mental health is not confined to a specific life stage but extends across every phase, from childhood and adolescence through adulthood.

Mental health pertains to a broad spectrum of conditions, including mood disorders like depression and bipolar disorder, anxiety disorders, personality disorders, and psychotic disorders such as schizophrenia. These conditions collectively underscore the multifaceted nature of mental health and its relevance throughout our lives.

Track 7: Neurodegenerative Diseases

Neurodegenerative diseases manifest when nerve cells in the brain or peripheral nervous system progressively lose function and eventually succumb. The fundamental mechanisms driving neurodegeneration (ND) are recognized as multifaceted, stemming from a combination of genetic, environmental, and internal factors associated with the aging process. While no definitive cures exist for neurodegenerative disorders like Parkinson's or Alzheimer's disease, there is a growing array of therapeutic and supportive interventions accessible to mitigate their impact.

Track 8: Neurological Diseases

A neurologic disorder arises from an aberration in the functioning of the brain or the nervous system, encompassing the spinal cord and nerves. This dysfunction can lead to both physical and psychological symptoms. The intricate development of the brain initiates before birth and persists throughout infancy, childhood, and adolescence.

Neurological issues may exhibit various origins. Some are congenital, present from birth, while others have a genetic basis. Certain disorders manifest suddenly due to injuries or illnesses, such as head trauma, stroke, or brain or spinal cancer. While many neurological conditions defy complete cure, physicians can employ rehabilitation to ameliorate symptoms and aid in the restoration of daily functioning.

Track 9: Parkinson Diseases

Parkinson's disease is a neurological condition characterized by involuntary or unmanageable movements, including tremors, rigidity, and challenges in maintaining balance and coordination. These symptoms typically emerge gradually and progress over time. Individuals with Parkinson's may have an increased susceptibility to severe and life-threatening infections. Nevertheless, thanks to advancements in treatment, the majority of those living with Parkinson's disease now enjoy a life expectancy that is either normal or close to normal.

Track 10: Psychology

Psychology encompasses the examination of the mind and behaviors in both human and non-human entities. Within its purview lies the exploration of conscious and unconscious processes, encompassing emotions and thoughts. It constitutes a broad academic discipline that transcends the boundaries between natural and social sciences. Additionally, it enhances our capacity to communicate with and comprehend others, further enriching our understanding of human behaviour and cognition.

Track 11: Public Awareness

Through open communication with others regarding the daily challenges you encounter, you can actively contribute to shaping legislation at local, state, and federal levels. The public health approach to Alzheimer's disease incorporates several key components. These include early detection and diagnosis, the reduction of risky health behaviors, and the collection and utilization of surveillance data. Raising awareness about Alzheimer's fosters greater comprehension and support for individuals grappling with memory loss. By gaining a deeper understanding of memory loss and the unique needs of patients, families, and caregivers, they can more effectively navigate the specific challenges they encounter. This heightened awareness also promotes self-understanding.

Track 12: Recent Developments in Dementia Treatment

The Food and Drug Administration (FDA) has recently granted full approval to a novel Alzheimer's treatment known as lecanemab. This medication has demonstrated the ability to moderately decelerate cognitive and functional decline in individuals with early-stage Alzheimer's disease. It received traditional approval from the US FDA for Alzheimer's disease treatment based on Phase 3 data derived from the Clarity AD clinical trial. Additionally, recent research suggests that older individuals with higher levels of triglycerides, a type of fat in the bloodstream, may experience a reduced risk of dementia and a slower cognitive decline over time when compared to those with lower triglyceride levels.

Track 13: Strokes and Neurocardiology

A stroke represents a critical medical emergency, as it can result in enduring brain damage, long-term disabilities, or even death. The indicators of a stroke can encompass a spectrum of symptoms, ranging from mild weakness to paralysis or numbness affecting one side of the face or body.

Furthermore, stroke-related cardiac damage can have severe consequences, potentially leading to fatality or the development of lifelong cardiac issues, such as heart failure. It can also result in milder and recoverable conditions like neurogenic stress cardiomyopathy (NSC) and Takotsubo cardiomyopathy. A stroke constitutes a sudden interruption of continuous blood flow to the brain, resulting in a loss of neurological function.

Track 14: Physiotherapy

Physiotherapy plays a crucial role in the restoration of mobility and functionality for individuals impacted by injuries, illnesses, or disabilities. Moreover, it serves to diminish the risk of future injuries or illnesses. This comprehensive approach actively engages the patient in their own care.

Physiotherapists assist individuals affected by injury, illness, or disability through methods such as movement and exercise, manual therapy, and the provision of valuable education and guidance. They promote overall well-being across all age groups, aiding patients in pain management and disease prevention.

Track 15: Medical Biotechnology and Alzheimer’s disease

Presently, medical biotechnology is ushering in newfound optimism for the management of Alzheimer's disease. An illustration of this progress can be found in on-going clinical trials, representing a significant breakthrough as the initial drug aimed at impeding or potentially arresting the advancement of Alzheimer's disease. In the field of structural techniques, both magnetic resonance imaging (MRI) and computed tomography (CT) are instrumental in offering insights. Meanwhile, functional imaging unveils the efficacy of cells in various brain regions by demonstrating the active utilization of sugar or oxygen.

Market Analysis

In 2023, the global Alzheimer's therapeutics market was valued at USD 4.05 billion, and it is projected to experience a robust compound annual growth rate (CAGR) of 19.99% from 2023 to 2030. This growth is primarily driven by the increasing prevalence of Alzheimer's disease (AD) and the approval of disease-modifying therapies. According to the National Centre for Biotechnology Information (NCBI), in 2021, an estimated 6.2 million individuals aged 65 and older in the United States were afflicted by Alzheimer's disease, with this number expected to surge to approximately 13.8 million by 2060.

Notably, women are more susceptible to Alzheimer's disease diagnosis compared to men, mainly due to their longer life expectancy. Additionally, Alzheimer's disease is emerging as the leading cause of mortality among neurodegenerative diseases and a common source of physical disability, necessitating urgent medical intervention.

Abstract Submission Criteria and Eligibility

Presentation Requirements:

  • Participating authors are answerable for registration, travel, and hotel costs. Note: Those with submitted abstracts will get an acknowledgment mail enabling them to enrol for the gathering.
  • Abstracts will be compiled, and conference books are made available to participants at the conference.
  • Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

Submission Options:

  • Oral paper introductions will have 30-minute schedule time slot. The keynote session will have for 45-minute presentation duration, workshop/special session will have 1-hour long schedule opening and symposium will have 1-hour long availability followed by 5-minute Q&A session.
  • Graduate and master’s understudies are qualified to present their abstracts under poster and e-poster presentation category.
  • Ph.D. understudies are qualified to submit their abstract under special YRF (Young Researcher's Forum), poster and e-poster presentation category.
  • NOTE: YRF category includes short oral presentation especially for Ph. D. students
  • Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

Participation Options and Benefits

Participation Options: Alzheimers Conference provides the participants with different modes or ways to participate such as Delegate or Speaker under ACADEMIC / STUDENT / BUSINESS Category.

  • Keynote speaker: 45-50 minutes
  • Speaker (oral presentation): 25-30 minutes (only one person can present)
  • Speaker (workshop): 45-50 minutes (more than 1 can present)
  • Speaker (special session): 45-50 minutes (more than 1 can present)
  • Speaker (symposium): more than 45 minutes (more than 1 can present)
  • Delegate (only registration): will have access to all the sessions with all the benefits of registration
  • Poster presenter:  can present a poster and enjoy the benefits of delegate
  • Remote attendance:  can participate via video presentation or e-poster presentation
  • Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
  • Media partner
  • Sponsor
  • Collaborator

Benefits of Joining Conference:

  • Get your abstract published with DOI
  • Get Certified for your participation
  • Reduced Costs Affordability
  • Knock Down Geographical Barriers
  • Convenience from comfort of your own home or from work
  • They’re Archived: Ability to view events in the recording
  • Great resource for learning new career skills
  • Learn from the Pros
  • Global exposure to your research
  • Make new connections
  • Significant time saving
  • Wider Reach
  • Position yourself as the expert
  • Get your abstracts published with unique DOI in International Journals
  • Get up to 50% discounts for publishing your entire article in our open access International Journals
  • Get Handbooks and conference kits
  • Get an access to the network with eminent personalities from worldwide.

To Collaborate Scientific Professionals around the World

Conference Date August 13-14, 2024

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal of Neurology and Neuroscience International Journal of Mental Health & Psychiatry Journal of Alzheimers Disease & Parkinsonism

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner